Skip to main content
Contact Us
Subscribe
E-Edition
82°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Macrogenics
(NQ:
MGNX
)
3.320
+0.040 (+1.22%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Macrogenics
< Previous
1
2
3
Next >
MGNX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
August 02, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
MacroGenics, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the MGNX Class Action
August 02, 2024
From
Robbins LLP
Via
Business Wire
NASDAQ:MGNX: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against MacroGenics, Inc.
July 31, 2024
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
MacroGenics Inc. (NASDAQ: MGNX) Leading the Way in Thursday Trading Based on Percentage Gain
April 04, 2024
Via
Investor Brand Network
MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
July 31, 2024
From
Schall Law
Via
GlobeNewswire
Shareholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against MacroGenics, Inc. (MGNX)
July 30, 2024
From
Robbins LLP
Via
GlobeNewswire
MACROGENICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against MacroGenics, Inc. and Encourages Investors to Contact the Firm
July 30, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 3/5
March 05, 2024
Via
Investor Brand Network
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/12
February 12, 2024
Via
Investor Brand Network
MACROGENICS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against MacroGenics, Inc. - MGNX
July 30, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
MacroGenics Provides Vobramitamab Duocarmazine Update
July 30, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte
July 30, 2024
Confirming cash runway guidance into 2026
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/6
February 06, 2024
Via
Investor Brand Network
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/1
February 01, 2024
Via
Investor Brand Network
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of MacroGenics, Inc. (MGNX) Investors
July 30, 2024
From
Kirby McInerney LLP
Via
Business Wire
MGNX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces That MacroGenics, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
July 30, 2024
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
July 29, 2024
From
The Schall Law Firm
Via
Business Wire
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 1/23
January 23, 2024
Via
Investor Brand Network
MACROGENICS, INC. (NASDAQ: MGNX) INVESTOR ALERT: Investors With Large Losses in MacroGenics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
July 29, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Rosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
July 29, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
MacroGenics to Participate in Upcoming Investor Conference
June 11, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
MACROGENICS ALERT: Bragar Eagel & Squire, P.C. is Investigating MacroGenics, Inc. on Behalf of MacroGenics Stockholders and Encourages Investors to Contact the Firm
May 14, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against MacroGenics, Inc. (MGNX)
May 13, 2024
From
Kirby McInerney LLP
Via
Business Wire
MacroGenics to Participate in Upcoming Investor Conferences
May 13, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and Encourages Investors to Contact the Firm
May 10, 2024
From
Schall Law
Via
GlobeNewswire
MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
May 03, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
April 03, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
March 01, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
February 27, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conference
February 02, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.